1. High stroke rate with rofecoxib and valdecoxib

   News item 26 February 2013 Pages: 1 - 1

2. US FDA reviewing safety of ezetimibe/simvastatin

   News item 26 February 2013 Pages: 2 - 2

3. The US FDA is informing healthcare professionals of two recent cases of progressive multifocal leukoencephalopathy (PML) associated with Tysabri

   News item 26 February 2013 Pages: 2 - 2

4. Warning against unauthorised ephedrine and kava kava products

   Media release 26 February 2013 Pages: 2 - 2

5. Health Canada and Pfizer have agreed on an acceptable ethyl methanesulfonate limit for Viracept [nelfinavir] and the drug can now be used again

   Media release 26 February 2013 Pages: 2 - 2

6. Temozolomide + radiotherapy: significant toxicity

   News item 26 February 2013 Pages: 3 - 3

7. The most frequently reported postmarketing adverse reactions associated with trastuzumab and rituximab were heart failure and WBC disorders,

   News item 26 February 2013 Pages: 3 - 3

8. Oral contraceptives: no significant fetal death risk

   News item 26 February 2013 Pages: 3 - 3

9. Intrathecal gemcitabine not recommended due to neurotoxicity

   News item 26 February 2013 Pages: 3 - 3

10. Antiepileptics: aromatic ring linked with allergy

    Incidence study 26 February 2013 Pages: 4 - 4

11. Measles increase a result of vaccine scare, says US CDC

    Clinical study 26 February 2013 Pages: 4 - 4

12. Reflex sneezing appears to be associated with the use of periocular anaesthetic injection under IV sedation,

    News item 26 February 2013 Pages: 4 - 4

13. Qiagen has announced the EU launch of a new test for detecting adverse reactions to abacavir.

    Media release 26 February 2013 Pages: 4 - 4

14. Albumin human

    Case report 26 February 2013 Pages: 5 - 5

15. Adalimumab

    Case report 26 February 2013 Pages: 5 - 5

16. Amantadine/pramipexole

    Case report 26 February 2013 Pages: 5 - 5

17. Amantadine withdrawal

    Case report 26 February 2013 Pages: 5 - 5

18. Analgesics

    Case report 26 February 2013 Pages: 6 - 6

19. Ampicillin/cefotaxime

    Case report 26 February 2013 Pages: 6 - 6

20. Aripiprazole

    Case report 26 February 2013 Pages: 7 - 7

21. Atorvastatin/fusidic acid interaction

    Case report 26 February 2013 Pages: 7 - 7

22. Azathioprine/infliximab

    Case report 26 February 2013 Pages: 7 - 7

23. Bevacizumab

    Case report 26 February 2013 Pages: 8 - 8

24. Betamethasone

    Case report 26 February 2013 Pages: 8 - 8

25. Bimatoprost

    Case report 26 February 2013 Pages: 8 - 8

26. Bevacizumab

    Case report 26 February 2013 Pages: 8 - 8

27. Calcium gluconate

    Case report 26 February 2013 Pages: 9 - 9

28. Botulinum toxin B

    Case report 26 February 2013 Pages: 9 - 9

29. Bupropion

    Case report 26 February 2013 Pages: 9 - 9

30. Carbamazepine/lamotrigine/valproate

    Case report 26 February 2013 Pages: 10 - 10

31. Carbamazepine

    Case report 26 February 2013 Pages: 10 - 10

32. Chloroprocaine

    Case report 26 February 2013 Pages: 11 - 11

33. Ceftriaxone

    Case report 26 February 2013 Pages: 11 - 11

34. Carob bean gum

    Case report 26 February 2013 Pages: 11 - 11

35. Ciprofloxacin

    Case report 26 February 2013 Pages: 12 - 12

36. Ciprofloxacin

    Case report 26 February 2013 Pages: 12 - 12

37. Contrast media

    Case report 26 February 2013 Pages: 12 - 12

38. Clozapine

    Case report 26 February 2013 Pages: 12 - 12

39. Corticosteroids/immunosuppressants

    Case report 26 February 2013 Pages: 12 - 13

40. Desmopressin

    Case report 26 February 2013 Pages: 13 - 13

41. Cyclophosphamide/vincristine

    Case report 26 February 2013 Pages: 13 - 13

42. Dexamethasone

    Case report 26 February 2013 Pages: 13 - 14

43. Doxorubicin/epirubicin

    Case report 26 February 2013 Pages: 14 - 14

    

44. Docetaxel/doxorubicin

    Case report 26 February 2013 Pages: 14 - 14

45. Dexamethasone

    Case report 26 February 2013 Pages: 14 - 14

46. Epinephrine

    Case report 26 February 2013 Pages: 15 - 15

47. Etanercept

    Case report 26 February 2013 Pages: 15 - 15

48. Erythromycin/methylprednisolone

    Case report 26 February 2013 Pages: 15 - 15

49. Fludarabine

    Case report 26 February 2013 Pages: 16 - 16

50. Geraniol/neomycin

    Case report 26 February 2013 Pages: 16 - 16